NCLP2

Across TCGA pan-cancer cohorts, NCLP2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of NCLP2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where NCLP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NCLP2 is over-expressed in tumor.

STAD are the cancer types where NCLP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NCLP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.015	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

NCLP2–STAD

Open the STAD breakdown →